Table S2.

Health, economic, and cost-effectiveness results for the base case

Canine intervention	Annual target (dogs)	Cumulative canine intervention costs* ($US)	Cumulative PEP costs* ($US)	Cumulative total costs* ($US)	DALYs*	ICER* ($US per DALY)
Status quo	0	0	14,341,778	14,341,778	17,008	NA
CV	100,000	11,894,017	14,064,424	25,958,440	6,090	1,064
CVFS	100,000	16,729,500	14,058,256	30,787,757	6,032	Dominated
CV	200,000	18,673,827	14,021,802	32,695,629	4,390	3,964
CVS	100,000	19,846,416	14,058,256	33,904,673	6,032	Dominated
CVFS	200,000	23,112,076	14,005,948	37,118,025	4,148	Dominated
CV	300,000	25,453,638	14,004,323	39,457,960	3,691	9,663
CVFS	300,000	31,975,814	13,976,308	45,952,122	3,340	Dominated
CV	400,000	32,233,448	13,994,568	46,228,016	3,299	17,300
CVS	200,000	34,570,416	14,005,948	48,576,364	4,148	Dominated
CV	500,000	39,013,258	13,988,247	53,001,505	3,045	Dominated
CVFS	400,000	39,823,800	13,959,046	53,782,846	3,007	25,869
CVFS	500,000	47,569,015	13,950,173	61,519,188	2,828	43,283
CVS	300,000	48,760,212	13,976,308	62,736,520	3,340	Dominated
CVS	400,000	60,296,928	13,959,046	74,255,973	3,007	Dominated
CVS	500,000	71,548,677	13,950,173	85,498,850	2,828	Dominated

CV, canine vaccination; CVS, canine vaccination and sterilization of males and females; CVFS, canine vaccination and female sterilization; NA, not applicable.

^*Cumulative over 10 y; discounted at 3% annually.